Drug‐associated glaucoma: A real‐world study based on the <scp>Food and Drug Administration</scp> adverse event reporting system database

Abstract

Preventing drug-associated glaucoma is more effective than treatment. Identifying the risk and drug-induced times of systemic and ophthalmic drugs can reduce occurrence risk. Clinical practitioners should be vigilant and inform patients of these risks.